AbiertaSubvenciónElegibilidad aún no verificada

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

National Institutes of Health · Cancer Control (93.399)

Publicada 5 nov 2024 · Quedan aproximadamente 13 meses

En pocas palabras

Resumen aún no disponible en español; se muestra en inglés.

The National Institutes of Health funds planning grants for clinical trials across cancer prevention and control, helping researchers address gaps in trial design, feasibility, and operational challenges. The program accepts applications from a wide range of US organisations including nonprofits, academic institutions, government bodies, and foreign organisations, with applications due by 25 October 2027.

Un resumen generado del texto del donante; la redacción original figura más abajo.

Resumen

Texto original del donante (inglés)

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of…

Extracto de la página del donante. El texto completo, los anexos y los formularios están en la convocatoria original.

Quién puede presentar una solicitud

  • ONG / sociedad civil
  • Institución académica o de investigación
  • Empresa privada
  • Organismo gubernamental
  • Organización comunitaria

Elegibilidad y condiciones

Mostrar el texto de elegibilidad de la fuente · Texto original del donante (inglés)

Applicant types: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Private institutions of higher education; Native American tribal governments (Federally recognized); Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; State governments; For profit organizations other than small businesses; Native American tribal organizations (other than Federally recognized tribal governments); Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public and State controlled institutions of higher education; Special district governments; Independent school districts

Other Eligible Applicants include the following:

Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Temas